Drug class
Selective alpha-1 adrenergic receptor antagonist; antihypertensive agent
Mechanism of action
Competitively blocks postsynaptic alpha-1 adrenoceptors, reducing peripheral vascular resistance. It also relaxes smooth muscle in the prostate.
General use cases
- Treatment of hypertension under the relevant product authorisation.
- Symptomatic relief of lower urinary tract symptoms associated with benign prostatic hyperplasia where authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
